$56MSeries C, 3 June 2025
Funds global commercialization of its drug ingredient production.
- Amount
- $56M
- Stage
- Series C
- Announced
- 3 June 2025
- Lead
- Global Health Investment Corporation
- Other investors
- EDBI
- Use of funds
- Funds global commercialization of its drug ingredient production.
- Checked
- Announced by the company
- Sources
- Antheia raises $56M Series C biospace.com
Antheia raises $56M Series C news.crunchbase.com